04:37 PM EDT, 07/03/2025 (MT Newswires) -- Eric Karas, Chief Commercial Officer, on July 01, 2025, sold 15,000 shares in Ars Pharmaceuticals ( SPRY ) for $254,861. Following the Form 4 filing with the SEC, Karas has control over a total of 10,315 common shares of the company, with 10,315 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1671858/000141588925019321/xslF345X05/form4-07032025_080720.xml